Popular Articles From: Cubist Announces Withdrawal of Listing of CVRs (CBSTZ) from NASDAQ Global Select Market to Deutsche Bank Gains Market Share in Fixed Income to Rank No 1 Globally


2015/1/13
Cubist Pharmaceuticals, Inc. (NASDAQ: CBST) today announced that it will voluntarily withdraw the contingent value rights (CVRs) it issued under a Contingent Value Rights Agreement dated October 24, 2013 (CVR Agreement) from listing on the NASDAQ Global Select Market on February 2, 2015, contemporaneously with their redemption.
Sign-up for Cubist Announces Withdrawal of Listing of CVRs (CBSTZ) from NASDAQ Global Select Market investment picks
2015/1/21
-- Agreement Provides Curis with Option to Exclusively License Aurigene's Antagonists for Immuno-Oncology, Including an Antagonist of PD-L1 and Selected Precision Oncology Targets, Including an IRAK4 Kinase Inhibitor --
Sign-up for Curis and Aurigene Announce Collaboration, License and Option Agreement to Discover, Develop and Commercialize Small Molecule Antagonists for Immuno-Oncology and Precision Oncology Targets investment picks
2015/1/14
Revolutionary Full-Service Bank Set to Disrupt Market NEW YORK , Jan.
Sign-up for Customers Bank Launches BankMobile: America's First And Only No Fee Mobile Bank investment picks
2014/12/17
CULVER CITY, Calif.
Sign-up for Cyber Attack Notification And AllClear ID Services investment picks
2014/12/15
CULVER CITY, Calif.
Sign-up for Cyber Attack Notification And AllClear ID Services investment picks
2015/1/12
CyberArk Software Ltd.
Sign-up for CyberArk Announces Release Date of Fourth Quarter and Full Year 2014 Financial Results investment picks
2014/12/30
MONMOUTH JUNCTION, N.J. , Dec.
Sign-up for CytoSorbents Submits IDE Application to FDA for U.S. CytoSorb® Cardiac Surgery Trial investment picks
2015/1/7
First HPAV2 MIMO-certified Device Extends Home Networks over Existing Power Lines LAS VEGAS , Jan.
Sign-up for D-Link Selects Broadcom's HomePlug® AV2 Technology for New AV2 2000 High Speed Powerline Adapter investment picks
2015/1/5
D.R. Horton, Inc. (NYSE:DHI), America’s Builder, announced today that the Company will release financial results for its first fiscal quarter ended December 31, 2014 on Monday, January 26, 2015 before the market opens.
Sign-up for D.R. Horton, Inc., America’s Builder, to Release 2015 First Quarter Earnings on January 26, 2015 investment picks
2014/12/15
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1164952&ProfileId=051205&sourceType=1 SANTA BARBARA, CA --
Sign-up for D2 Technologies and Alcatel-Lucent Complete Interoperability Testing of VoLTE and RCS investment picks
2014/12/21
Luxury real estate developer DAMAC Properties is offering new buyers of its villas or apartments the opportunity to live a James Bond lifestyle, with an exclusive offer during the Dubai Shopping Festival.
Sign-up for DAMAC Properties’ Dubai Shopping Festival Car Promotion Back with Mercedes-Benz & Aston Martin investment picks
2014/12/8
95% (19/20) Overall Response Rate (ORR) in Patients with High-Risk CLL, the patient population to be studied in recently announced Phase 3 Clinical Trial being conducted under Special Protocol Assessment (SPA) 87% (34/39) ORR per iwCLL criteria in all evaluable CLL patients plus an additional 10% of patients with a nodal PR or nodal reductions ranging from 20%-45% without disease progression 88% (7/8) ORR in all evaluable Mantle Cell Lymphoma (MCL) patients with a 38% (3/8) Complete Response rate Combination of TG-1101 + Ibrutinib well tolerated with limited Grade 3/4 events reported to date SAN FRANCISCO, Dec.
Sign-up for Data From Phase 2 Clinical Trial of TG-1101 (Ublituximab) and Ibrutinib Shows Compelling Clinical Activity in Patients With Previously Treated, High-Risk Chronic Lymphocytic Leukemia (CLL) investment picks
2014/12/10
Merck (NYSE: MRK), known as MSD outside the United States and Canada, announced today early study findings demonstrating an overall response rate of 18.5 percent with KEYTRUDA, the company’s anti-PD-1 therapy, as assessed by RECIST v1.1, central review (n=5/27), in PD-L1 positive, advanced triple-negative breast cancer – one of the most aggressive forms of breast cancer.
Sign-up for Data Investigating KEYTRUDA® (pembrolizumab), Merck’s Anti-PD-1 Therapy, in Patients with Advanced Triple-Negative Breast Cancer Presented at 2014 San Antonio Breast Cancer Symposium investment picks
2014/12/17
SAN FRANCISCO , Dec.
Sign-up for Dates Set for PG&E Quarterly Stock Dividends investment picks
2014/12/29
Year Marked by Continued Clinical Excellence, Commitment to Patient Services, Innovative Partnerships, International Growth, Community Leadership DENVER , Dec.
Sign-up for DaVita HealthCare Partners Celebrates Milestones of 2014 investment picks
2015/2/2
MIDLAND, Texas , Feb.
Sign-up for Dawson Geophysical to File a Quarterly Report on Form 10-Q for First Quarter 2015 Results investment picks
2015/1/30
DENVER, Jan.
Sign-up for DCP Midstream Announces Corporate Restructuring investment picks
2015/1/12
BEACHWOOD, Ohio , Jan.
Sign-up for DDR Prices $500 Million Offering of 3.625% Senior Unsecured Notes investment picks
2015/1/12
SAN DIEGO, Jan.
Sign-up for Deadline in Lawsuit for Investors in InvenSense Inc (INVN) Shares Announced by Shareholders Foundation investment picks
2015/1/7
SIGA Technologies, Inc. (Nasdaq:SIGA), a company operating under the protection of the United States Bankruptcy Court for the Southern District of New York and specializing in the development and commercialization of solutions for serious unmet medical needs and biothreats, announced that on January 7, 2015, the Delaware Court of Chancery, acting on remand from the Delaware Supreme Court, issued a letter opinion in the litigation begun by PharmAthene, Inc. in 2006.
Sign-up for Delaware Court Decision Regarding SIGA Technologies, Inc. investment picks
2015/1/2
Today, Delaware Enhanced Global Dividend and Income Fund (the “Fund”), a New York Stock Exchange–listed closed-end fund trading under the symbol “DEX,” declares a monthly dividend of $0.0750 per share.
Sign-up for Delaware Enhanced Global Dividend and Income Fund Announces Dividends investment picks
2014/12/15
China leads the way with 82% of DR capital raised; DRs expected to rise 25% in trading value and 6% in trading volume by year end 2014 NEW YORK , Dec.
Sign-up for Depositary Receipt Capital Raising More Than Triples in 2014 to Highest Level since Financial Crisis investment picks
2014/12/18
Qualcomm Incorporated is a world leader in 3G, 4G and next-generation wireless technologies.
Sign-up for Derek Aberle, President of Qualcomm Incorporated, Hosts Company Press Conference at CES 2015 investment picks
2015/1/15
Ford Motor Company (NYSE: F) will release its preliminary 2014 fourth quarter and full-year financial results at 7 a.m. EST Thursday, Jan.
Sign-up for Details of Ford Motor Company’s January 29 Briefing on 2014 Fourth Quarter and Full-Year Results investment picks
2015/1/14
Deutsche Asset & Wealth Management (Deutsche AWM) today announced that Mihir Meswani and Nicolas Laporte have joined as Portfolio Managers to further strengthen the firm’s Hedge Fund Advisory business.
Sign-up for Deutsche Asset & Wealth Management Hires Two Portfolio Managers for Hedge Fund Advisory Business investment picks
2014/12/3
Deutsche Asset & Wealth Management (“Deutsche AWM”) announced today the launch of the Deutsche European Equity Fund (tickers: Class A – DURAX, Class C – DURCX, Class INST – DURIX, Class S - DURSX) (“the Fund”). The Fund is an open-end mutual fund that seeks long-term capital appreciation by investing in companies headquartered in Europe across a range of countries, sectors and capitalizations.
Sign-up for Deutsche Asset & Wealth Management Launches Actively-Managed Mutual Fund for European Equities investment picks
2015/1/7
By Justin Baer Deutsche Bank AG took another step to shore up its back office in the Americas, hiring a finance director from HSBC Holdings PLC and promoting one of its own executives to help form the lender's U.S. holding company.
Sign-up for Deutsche Bank beefs up Americas back office investment picks
2015/1/20
Greenwich Associates’ 2014 Global Fixed Income survey, published today, shows Deutsche Bank has increased its fixed income market share by 10 basis points to 10.1% over the past year to rank No.1 for the fifth year running.
Sign-up for Deutsche Bank Gains Market Share in Fixed Income to Rank No 1 Globally investment picks
Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Popular Articles From: Cubist Announces Withdrawal of Listing of CVRs (CBSTZ) from NASDAQ Global Select Market to Deutsche Bank Gains Market Share in Fixed Income to Rank No 1 Globally
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Title |  Date |  Author |  Collection |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent